COMMITMENTS & CONTINGENCIES (Tables)

6 Months Ended

Jun. 30, 2020

COMMITMENTS AND CONTINGENCIES

Contractual Obligation, Fiscal Year Maturity [Table Text Block]

				Future Commitments
Commitment	Counter Party	Product Relationship	Commitment Type	2020		2021		2022		2023		2024 & After		Total
Research Agreement	KeyGene	Hemp / Cannabis	Contract fee	$	600	$	1,200	$	1,200	$	1,200	$	295	$	4,495	(1)
License Agreement	NCSU	Tobacco	Annual royalty fee		113		225		225		—		—		563	(2), (3)
License Agreement	NCSU	Tobacco	Minimum annual royalty		25		25		50		50		650		800	(3)
License Agreement	NCSU	Tobacco	Minimum annual royalty		50		50		50		50		550		750	(3)
Sublicense Agreement	Anandia Laboratories, Inc.	Hemp / Cannabis	Annual license fee		10		10		10		10		120		160	(4)
Growing Agreement	Various	Various	Contract fee		75		—		—		—		—		75	(5)
				$	873	$	1,510	$	1,535	$	1,310	$	1,615	$	6,843

(1) Exclusive agreement with the Company with respect to the Cannabis Sativa L. plant (the "Field"). The initial term of the agreement is five years with an option for an additional two years. The aggregate cost of the agreement over the initial term is $6,000. The Company will exclusively own all results and all intellectual property relating to the results of the collaboration with KeyGene (the "Results”). The Company will pay royalties in varying amounts to KeyGene relating to the Company's commercialization in the Field of certain Results. The Company has granted KeyGene a license to commercialize the Results outside of the Field and KeyGene will pay royalties in varying amounts to the Company relating to KeyGene's commercialization outside of the Field of the Results.

(2) The license agreement also requires a milestone payment of $150 upon FDA approval or clearance of a product that uses the NCSU licensed technology. The annual royalty fee is credited against running royalties on sales of licensed products.

(3) The Company is also responsible for reimbursing NSCU for actual third-party patent costs incurred, including capitalized patent costs and patent maintenance costs. These costs vary from year to year and the Company has certain rights to direct the activities that result in these costs.

(4) The Company is also responsible for the payment of certain costs, including, capitalized patent costs and patent maintenance costs, a running royalty on future net sales of products made from the sublicensed intellectual property, and a sharing of future sublicensing consideration received from sublicensing to third parties.

(5) Various R&D growing agreements for hemp / cannabis and tobacco.